Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study-Reference-Cited by-同舟云学术

Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study

Published:2010-07-07 Issue:1 Volume:11 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Junyent Mireia,Martínez Montserrat,Borràs Mercè,Coll Blai,Valdivielso Jose Manuel,Vidal Teresa,Sarró Felipe,Roig Jordi,Craver Lourdes,Fernández Elvira

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/article/10.1186/1471-2369-11-14/fulltext.html

Reference33 articles.

1. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lamiere N: Chronic kidney disease as a cause of cardiovascular morbidity and mortality. Nephrol Dial Transpl. 2005, 20: 1048-1056. 10.1093/ndt/gfh813.

2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.

3. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998, 9 (Suppl 12): 16-23.

4. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003, 108: 2154-2169. 10.1161/01.CIR.0000095676.90936.80.

5. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort;Clinical Kidney Journal;2023-10-10

2. Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men;Clinical Kidney Journal;2023-10-09

3. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease;Science Translational Medicine;2023-09-06

4. B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease;Clinical Science;2023-09

5. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study;Atherosclerosis;2023-06